192 related articles for article (PubMed ID: 21973227)
1. Adult ADHD: prevalence of diagnosis in a US population with employer health insurance.
Montejano L; Sasané R; Hodgkins P; Russo L; Huse D
Curr Med Res Opin; 2011; 27 Suppl 2():5-11. PubMed ID: 21973227
[TBL] [Abstract][Full Text] [Related]
2. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
3. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
[TBL] [Abstract][Full Text] [Related]
6. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.
Sankaranarayanan J; Puumala SE; Kratochvil CJ
Curr Med Res Opin; 2006 Aug; 22(8):1475-91. PubMed ID: 16870073
[TBL] [Abstract][Full Text] [Related]
8. Trends in medication treatment for ADHD.
Castle L; Aubert RE; Verbrugge RR; Khalid M; Epstein RS
J Atten Disord; 2007 May; 10(4):335-42. PubMed ID: 17449832
[TBL] [Abstract][Full Text] [Related]
9. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit hyperactivity disorder and increased risk of injury.
Merrill RM; Lyon JL; Baker RK; Gren LH
Adv Med Sci; 2009; 54(1):20-6. PubMed ID: 19586835
[TBL] [Abstract][Full Text] [Related]
12. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
13. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(44):1439-43. PubMed ID: 21063274
[TBL] [Abstract][Full Text] [Related]
14. Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15-44 Years - United States, 2003-2015.
Anderson KN; Ailes EC; Danielson M; Lind JN; Farr SL; Broussard CS; Tinker SC
MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(2):66-70. PubMed ID: 29346342
[TBL] [Abstract][Full Text] [Related]
15. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders.
Pérez de Los Cobos J; Siñol N; Puerta C; Cantillano V; López Zurita C; Trujols J
Psychiatry Res; 2011 Jan; 185(1-2):205-10. PubMed ID: 20537723
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study.
Cohen R; Senecky Y; Shuper A; Inbar D; Chodick G; Shalev V; Raz R
J Child Neurol; 2013 Jan; 28(1):120-3. PubMed ID: 22550087
[TBL] [Abstract][Full Text] [Related]
17. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
[TBL] [Abstract][Full Text] [Related]
18. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence in adults of attention deficit hyperactivity disorder using the medical records of primary care].
Aragonès E; Lluís Piñol J; Ramos-Quiroga JA; López-Cortacans G; Caballero A; Bosch R
Rev Esp Salud Publica; 2010; 84(4):417-22. PubMed ID: 21141268
[TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder.
Levy LD; Fleming JP; Klar D
Int J Obes (Lond); 2009 Mar; 33(3):326-34. PubMed ID: 19223848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
